Aging is not a mystery, says famed researcher Dr. Aubrey de Grey, perhaps the world’s foremost advocate of the provocative view that medical technology will one day allow humans to control the aging process and live healthily into our hundreds—or even thousands.
“The cultural attitudes toward all of this are going to be completely turned upside down by sufficiently promising results in the lab, in mice.”
He likens aging to a car wearing down over time; as the body operates normally, it accumulates damage which can be tolerated for a while, but eventually sends us into steep decline. The most promising way to escape this biological reality, he says, is to repair the damage as needed with precise scientific tools.
I’m a believer in Dr. Aubrey de Grey’s efforts. I’m double my money investing in Crispr Technology with EDIT, and Dr. George Church’s research in aging, plus. Science will get there. It’s only a matter of time, folks.
I advocate that investors wake up to the promise of Crispr, Dr. Aubrey, and other such technologies just as they have to Elon Musk and Tesla, Spacex, Solar City +. Investors should invest in Companies like EDIT, NTLA, and others, driving the share price higher; thereby, providing the added funds needed to get the research done.
The research in those technologies is a “Holy Grail” of future medicine. When your dealing with this kind of hope the share price is not always the right way to invest in a dream.